Press Release

Posted on: twenty eight Jul 17

RANCHO CORDOVA, Calif., July 28, two thousand seventeen (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing, today announced that the U.S. Patent and Trademark Office has awarded a fresh U.S. Patent, No. 9,695,394 (the ‘394 patent’), entitled “Cell Separation Devices, Systems, and Methods.” The patent was awarded to SynGen, Inc., whose cell processing assets were acquired by ThermoGenesis Corp., Cesca’s 80%-owned device subsidiary, on July Ten, 2017. Continue reading →